Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes.

Robinson KA, Hegyi K, Hannun YA, Buse MG, Sethi JK.

PLoS One. 2014 Oct 15;9(10):e108963. doi: 10.1371/journal.pone.0108963. eCollection 2014.

2.

Posttranslational regulation of thioredoxin-interacting protein.

Robinson KA, Brock JW, Buse MG.

J Mol Endocrinol. 2012 Dec 31;50(1):59-71. doi: 10.1530/JME-12-0091. Print 2013 Feb.

PMID:
23152583
3.

O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.

Klein AL, Berkaw MN, Buse MG, Ball LE.

Mol Cell Proteomics. 2009 Dec;8(12):2733-45. doi: 10.1074/mcp.M900207-MCP200. Epub 2009 Aug 11.

4.

Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation.

Robinson KA, Buse MG.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E870-81. doi: 10.1152/ajpendo.00644.2007. Epub 2008 Feb 26. Erratum in: Am J Physiol Endocrinol Metab. 2008 Jul;295(1): E223.

5.

Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes.

Robinson KA, Ball LE, Buse MG.

Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E884-90. Epub 2006 Nov 22.

6.

Glucose, dexamethasone, and the unfolded protein response regulate TRB3 mRNA expression in 3T3-L1 adipocytes and L6 myotubes.

Yacoub Wasef SZ, Robinson KA, Berkaw MN, Buse MG.

Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1274-80. Epub 2006 Jul 11.

7.

Hexosamines, insulin resistance, and the complications of diabetes: current status.

Buse MG.

Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. Review.

8.
9.

At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes.

Robinson KA, Yacoub Wasef SZ, Buse MG.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):93-8. Epub 2005 Jul 12.

PMID:
16019120
10.

Effect of R(+)alpha-lipoic acid on pyruvate metabolism and fatty acid oxidation in rat hepatocytes.

Walgren JL, Amani Z, McMillan JM, Locher M, Buse MG.

Metabolism. 2004 Feb;53(2):165-73.

PMID:
14767867
11.

High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.

Walgren JL, Vincent TS, Schey KL, Buse MG.

Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E424-34. Epub 2002 Oct 22.

12.

Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles.

Buse MG, Robinson KA, Marshall BA, Hresko RC, Mueckler MM.

Am J Physiol Endocrinol Metab. 2002 Aug;283(2):E241-50.

13.

Defective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance.

Nelson BA, Robinson KA, Buse MG.

Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E497-506.

14.

Insulin acutely regulates Munc18-c subcellular trafficking: altered response in insulin-resistant 3T3-L1 adipocytes.

Nelson BA, Robinson KA, Buse MG.

J Biol Chem. 2002 Feb 8;277(6):3809-12. Epub 2001 Dec 18.

15.
16.

Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons.

Nakamura M, Barber AJ, Antonetti DA, LaNoue KF, Robinson KA, Buse MG, Gardner TW.

J Biol Chem. 2001 Nov 23;276(47):43748-55. Epub 2001 Sep 17.

18.

High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes.

Nelson BA, Robinson KA, Buse MG.

Diabetes. 2000 Jun;49(6):981-91.

PMID:
10866051
19.

Lower calorie intake enhances muscle insulin action and reduces hexosamine levels.

Gazdag AC, Wetter TJ, Davidson RT, Robinson KA, Buse MG, Yee AJ, Turcotte LP, Cartee GD.

Am J Physiol Regul Integr Comp Physiol. 2000 Feb;278(2):R504-12.

20.

Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle.

Kurowski TG, Lin Y, Luo Z, Tsichlis PN, Buse MG, Heydrick SJ, Ruderman NB.

Diabetes. 1999 Mar;48(3):658-63.

PMID:
10078574
21.

Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. reversal with GH, but not IGF-I, therapy.

Robinson KA, Willi SM, Bingel S, Buse MG.

Am J Physiol. 1999 Mar;276(3):E435-42. doi: 10.1152/ajpendo.1999.276.3.E435.

PMID:
10070007
22.

Diabetes research in South Carolina: past, present, and future.

Willi SM, O'Rear D, Garvey WT, Colwell JA, Buse MG, Jaffa A, Lopes-Virella M, Wood D, Mayfield RK, Wallace P, Hermayer KL, Jenkins AJ, Lyons T, Mayer-Davis E.

J S C Med Assoc. 1998 Nov;94(11):502-8.

PMID:
9844316
23.

Human recombinant alpha 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase.

Kalabay L, Chavin K, Lebreton JP, Robinson KA, Buse MG, Arnaud P.

Horm Metab Res. 1998 Jan;30(1):1-6.

PMID:
9503031
24.

Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells.

Chen H, Ing BL, Robinson KA, Feagin AC, Buse MG, Quon MJ.

Mol Cell Endocrinol. 1997 Nov 30;135(1):67-77.

PMID:
9453242
25.

Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice.

Buse MG, Robinson KA, Gettys TW, McMahon EG, Gulve EA.

Am J Physiol. 1997 Jun;272(6 Pt 1):E1080-8.

PMID:
9227455
26.

Effects of exercise and feeding on the hexosamine biosynthetic pathway in rat skeletal muscle.

Nelson BA, Robinson KA, Koning JS, Buse MG.

Am J Physiol. 1997 May;272(5 Pt 1):E848-55.

PMID:
9176185
27.

Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice.

Buse MG, Robinson KA, Marshall BA, Mueckler M.

J Biol Chem. 1996 Sep 20;271(38):23197-202.

28.

Synergistic effects of insulin and phorbol ester on mitogen-activated protein kinase in Rat-1 HIR cells.

Knoepp SM, Wisehart-Johnson AE, Buse MG, Bradshaw CD, Ella KM, Meier KE.

J Biol Chem. 1996 Jan 19;271(3):1678-86.

29.

Characterization of a mutant GLUT4 lacking the N-glycosylation site: studies in transfected rat adipose cells.

Ing BL, Chen H, Robinson KA, Buse MG, Quon MJ.

Biochem Biophys Res Commun. 1996 Jan 5;218(1):76-82.

PMID:
8573180
30.

Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver.

Robinson KA, Weinstein ML, Lindenmayer GE, Buse MG.

Diabetes. 1995 Dec;44(12):1438-46.

PMID:
7589852
31.
32.

Effect of immobilization on glucose transporter expression in rat hindlimb muscles.

Didyk RB, Anton EE, Robinson KA, Menick DR, Buse MG.

Metabolism. 1994 Nov;43(11):1389-94.

PMID:
7968595
33.

Delayed processing of the insulin proreceptor by hepatocytes from diabetic rats.

Koh G, Robinson KA, Buse MG.

Biochem Biophys Res Commun. 1994 Oct 28;204(2):725-31.

PMID:
7980535
34.

Scintigraphic diagnosis of peritoneo-pleural communication in the absence of ascites.

Daly JJ, Potts JM, Gordon L, Buse MG.

Clin Nucl Med. 1994 Oct;19(10):892-4.

PMID:
7805325
35.

Sequential activation of two mitogen activated protein (MAP) kinase isoforms in rat skeletal muscle following insulin injection.

Zhou GX, Meier KE, Buse MG.

Biochem Biophys Res Commun. 1993 Dec 15;197(2):578-84.

PMID:
8267593
37.

Okadaic acid, insulin, and denervation effects on glucose and amino acid transport and glycogen synthesis in muscle.

Robinson KA, Boggs KP, Buse MG.

Am J Physiol. 1993 Jul;265(1 Pt 1):E36-43.

PMID:
8338152
38.

Phosphorylation of the rodent negative acute-phase protein alpha 1-inhibitor-III by the insulin receptor tyrosine kinase.

Komori K, Robinson KA, Block NE, Roberts RC, Buse MG.

Endocrinology. 1992 Sep;131(3):1288-96.

PMID:
1380438
39.
40.

Skeletal muscle insulin-receptor kinase. Effects of substrate inhibition and diabetes.

Block NE, Komori K, Dutton SL, Robinson KA, Buse MG.

Diabetes. 1991 Dec;40(12):1691-700.

PMID:
1661694
41.

Increased hepatic insulin proreceptor-to-receptor ratio in diabetes: a possible processing defect.

Dardevet D, Komori K, Grunfeld C, Rosenzweig SA, Buse MG.

Am J Physiol. 1991 Nov;261(5 Pt 1):E562-71.

PMID:
1951680
42.

Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle.

Block NE, Menick DR, Robinson KA, Buse MG.

J Clin Invest. 1991 Nov;88(5):1546-52.

43.

Effects of insulin and phospholipase C in control and denervated rat skeletal muscle.

Sowell MO, Boggs KP, Robinson KA, Dutton SL, Buse MG.

Am J Physiol. 1991 Feb;260(2 Pt 1):E247-56.

PMID:
1847587
44.

Insulin administration in vivo increases 1,2-diacylglycerol in rat skeletal muscle.

Boggs KP, Farese RV, Buse MG.

Endocrinology. 1991 Jan;128(1):636-8.

PMID:
1986947
45.

Diabetes-associated impairment of hepatic insulin receptor tyrosine kinase activity: a study of mechanisms.

Block NE, Komori K, Robinson KA, Dutton SL, Lam CF, Buse MG.

Endocrinology. 1991 Jan;128(1):312-22.

PMID:
1846101
46.
47.
48.

Glucocorticoid regulation of muscle branched-chain amino acid metabolism.

Block KP, Buse MG.

Med Sci Sports Exerc. 1990 Jun;22(3):316-24.

PMID:
2381301
49.

Placental localization in abdominal pregnancy using technetium-99m-labeled red blood cells.

Martin B, Payan JM, Jones JS, Buse MG.

J Nucl Med. 1990 Jun;31(6):1106-9.

50.

Growth factor binding and bioactivity in human kidney epithelial cell cultures.

Gansler T, Hsu WC, Gramling TS, Robinson KA, Buse MG, Blocker N, Roy L, Green S, Garvin AJ, Sens DA.

In Vitro Cell Dev Biol. 1990 Mar;26(3 Pt 1):285-90.

PMID:
2156796

Supplemental Content

Support Center